• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A model for the evaluation of domain based classification of GPCR.

作者信息

Kumari Tannu, Pant Bhaskar, Pardasani Kamalraj Raj

机构信息

Department of Mathematics, MANIT, Bhopal - 462051, India.

出版信息

Bioinformation. 2009 Oct 11;4(4):138-42.

PMID:20198189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2825592/
Abstract

G-Protein Coupled Receptors (GPCR) are the largest family of membrane bound receptor and plays a vital role in various biological processes with their amenability to drug intervention. They are the spotlight for the pharmaceutical industry. Experimental methods are both time consuming and expensive so there is need to develop a computational approach for classification to expedite the drug discovery process. In the present study domain based classification model has been developed by employing and evaluating various machine learning approaches like Bagging, J48, Bayes net, and Naive Bayes. Various softwares are available for predicting domains. The result and accuracy of output for the same input varies for these software's. Thus, there is dilemma in choosing any one of it. To address this problem, a simulation model has been developed using well known five softwares for domain prediction to explore the best predicted result with maximum accuracy. The classifier is developed for classification up to 3 levels for class A. An accuracy of 98.59% by Naïve Bayes for level I, 92.07% by J48 for level II and 82.14% by Bagging for level III has been achieved.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1648/2825592/bf0d654ff968/97320630004138F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1648/2825592/bf0d654ff968/97320630004138F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1648/2825592/bf0d654ff968/97320630004138F1.jpg

相似文献

1
A model for the evaluation of domain based classification of GPCR.
Bioinformation. 2009 Oct 11;4(4):138-42.
2
GPCR-MPredictor: multi-level prediction of G protein-coupled receptors using genetic ensemble.GPCR-MPredictor:基于遗传集成的 G 蛋白偶联受体多层次预测
Amino Acids. 2012 May;42(5):1809-23. doi: 10.1007/s00726-011-0902-6. Epub 2011 Apr 20.
3
Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence.基于机器学习智能的 G 蛋白偶联受体变构调节剂的综合多类分类和预测。
Biomolecules. 2021 Jun 11;11(6):870. doi: 10.3390/biom11060870.
4
Protein classification based on text document classification techniques.基于文本文档分类技术的蛋白质分类。
Proteins. 2005 Mar 1;58(4):955-70. doi: 10.1002/prot.20373.
5
A naive Bayes model to predict coupling between seven transmembrane domain receptors and G-proteins.一种用于预测七跨膜结构域受体与G蛋白之间偶联的朴素贝叶斯模型。
Bioinformatics. 2003 Jan 22;19(2):234-40. doi: 10.1093/bioinformatics/19.2.234.
6
A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.基于包装特征选择和类别平衡的药物-靶标相互作用预测的机器学习方法。
Mol Inform. 2020 May;39(5):e1900062. doi: 10.1002/minf.201900062. Epub 2020 Feb 11.
7
A Novel Blunge Calibration Intelligent Feature Classification Model for the Prediction of Hypothyroid Disease.一种用于预测甲状腺功能减退症的新型布隆智能特征分类模型。
Sensors (Basel). 2023 Jan 18;23(3):1128. doi: 10.3390/s23031128.
8
Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods.基于转录组谱特征选择和机器学习方法的乳腺癌预测。
BMC Bioinformatics. 2022 Oct 1;23(1):410. doi: 10.1186/s12859-022-04965-8.
9
Classifying G-protein coupled receptors with bagging classification tree.利用装袋分类树对G蛋白偶联受体进行分类。
Comput Biol Chem. 2004 Oct;28(4):275-80. doi: 10.1016/j.compbiolchem.2004.08.001.
10
Machine Learning Hybrid Model for the Prediction of Chronic Kidney Disease.机器学习混合模型预测慢性肾脏病。
Comput Intell Neurosci. 2023 Mar 14;2023:9266889. doi: 10.1155/2023/9266889. eCollection 2023.

引用本文的文献

1
Serotonin receptors in hippocampus.海马体中的血清素受体。
ScientificWorldJournal. 2012;2012:823493. doi: 10.1100/2012/823493. Epub 2012 May 2.

本文引用的文献

1
On the hierarchical classification of G protein-coupled receptors.关于G蛋白偶联受体的层次分类
Bioinformatics. 2007 Dec 1;23(23):3113-8. doi: 10.1093/bioinformatics/btm506. Epub 2007 Oct 22.
2
Reduced alphabet motif methodology for GPCR annotation.用于G蛋白偶联受体注释的简化字母基序方法。
J Biomol Struct Dyn. 2007 Dec;25(3):299-310. doi: 10.1080/07391102.2007.10507178.
3
GLIDA: GPCR-ligand database for chemical genomic drug discovery.GLIDA:用于化学基因组药物发现的GPCR配体数据库。
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D673-7. doi: 10.1093/nar/gkj028.
4
Prediction of G-protein-coupled receptor classes.G蛋白偶联受体类别的预测。
J Proteome Res. 2005 Jul-Aug;4(4):1413-8. doi: 10.1021/pr050087t.
5
Classifying G-protein coupled receptors with bagging classification tree.利用装袋分类树对G蛋白偶联受体进行分类。
Comput Biol Chem. 2004 Oct;28(4):275-80. doi: 10.1016/j.compbiolchem.2004.08.001.
6
PRED-GPCR: GPCR recognition and family classification server.PRED-GPCR:G蛋白偶联受体识别与家族分类服务器。
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W380-2. doi: 10.1093/nar/gkh431.
7
Proteome-wide classification and identification of mammalian-type GPCRs by binary topology pattern.通过二元拓扑模式对哺乳动物型G蛋白偶联受体进行全蛋白质组分类和鉴定
Comput Biol Chem. 2004 Feb;28(1):39-49. doi: 10.1016/j.compbiolchem.2003.11.003.
8
Depicting a protein's two faces: GPCR classification by phylogenetic tree-based HMMs.描绘蛋白质的两面:基于系统发育树的隐马尔可夫模型对GPCR的分类
FEBS Lett. 2003 Nov 6;554(1-2):95-9. doi: 10.1016/s0014-5793(03)01112-8.
9
Motif3D: Relating protein sequence motifs to 3D structure.Motif3D:将蛋白质序列基序与三维结构相关联。
Nucleic Acids Res. 2003 Jul 1;31(13):3333-6. doi: 10.1093/nar/gkg534.
10
The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.人类基因组中的G蛋白偶联受体形成五个主要家族。系统发育分析、旁系同源基因组群和指纹图谱。
Mol Pharmacol. 2003 Jun;63(6):1256-72. doi: 10.1124/mol.63.6.1256.